Aptose Biosciences Inc Cash Flow Statement

APTO $3.94 -0.1 -2.5%

03/03/21

Adventurous, Small Cap, Sucker Stock

Market Cap £256.6m

Enterprise Value £187.8m

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock Aptose Biosciences Inc's cashflow statement please upgrade your membership.

	2014	2015	2016	2017	2018	2019
Period End:	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31
Period Length:	7M	12M	12M	12M	12M	12M
Currency:	USD	USD	USD	USD	USD	USD

Net Income/Starting Line

Depreciation/Depletion
Non-Cash Items
Other Non-Cash Items
Changes in Working Capital
Prepaid Expenses
Other Assets
Accounts Payable
Accrued Expenses
Other Assets & Liabilities, Net
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Other Investing Cash Flow Items, Total
Investment, Net
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Foreign Exchange Effects
Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.